Socioeconomic variations in the prevalence and incidence of Parkinson's disease: A population-based analysis

Journal of Epidemiology and Community Health

Volumn 64, Issue 4, 2010, Pages 335-340

  Lix, Lisa M ^a   Hobson, Douglas E ^b   Azimaee, Mahmoud ^c   Leslie, William D ^b   Burchill, Charles ^c   Hobson, Shaun ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE INCIDENCE; DISEASE PREVALENCE; HEALTH INSURANCE; HOUSEHOLD INCOME; MENTAL HEALTH; SOCIOECONOMIC STATUS; SPATIOTEMPORAL ANALYSIS; URBAN AREA;

ADULT; AGE; ARTICLE; CANADA; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PARKINSON DISEASE; POVERTY; PREVALENCE; SOCIAL CLASS; SOCIOECONOMICS; STATISTICS;

ADULT; AGE FACTORS; FEMALE; HUMANS; INCIDENCE; MALE; MANITOBA; MIDDLE AGED; PARKINSON DISEASE; POVERTY; PREVALENCE; SOCIAL CLASS; SOCIOECONOMIC FACTORS; YOUNG ADULT;

CANADA; MANITOBA;

EID: 77950231728     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2008.084954     Document Type: Article

References (40)

1. Findley L, Aujla M, Bain PG, et al. Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord 2003: 18: 1139-1189
2. Guttmen M, Slaughter PM, Theriault M-E, et al. Parkinsonism in Ontario: physician utilization. Can J Neurol Sci 2002; 29: 221-226
3. Pressley JC, Louis ED, Tang MX, et al. The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 2003; 60: 87-93.
4. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384-386
5. Ven Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003; 157: 1015-1022
6. Guttmen M, Slaughter PM, Theriault M, et al. Burden of parkinsonism: a populationbased study. Mov Disord 2003; 18: 313-336
7. Twelves D, Perkins KSM, Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003; 18: 19-31.
8. Dalstra JA, Kunst AE, Borrell C, et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol 2005: 34: 316-326
9. Li X, Sundquist J, Sundquist K. Socioeconomic and occupational groups and Parkinson's disease: a nationwide study based on hospitalizations in Sweden. Int Arch Occup Environ Health 2009: 82: 235-241
10. Pressley JC, Tang MX, Marder K, et al. Disparities in the recording of Parkinson's disease on death certificates. Mov Disord 2005; 20: 315-321
11. Statistics Canada. 2006 community profiles, http://www.12.statcan.ca/ english/census06/data/profiles/community (accessed 31 Oct 2008).
12. Watson DE, Katz A, Reid RJ, et al. Family physician workloads and access to care in Winnipeg: 1991 to 2001. Can Med Assoc J 2001; 171: 339-342
13. Roos LL, Nicol JP, Cageorge SM. Using administrative data for longitudinal research: Comparisons with primary data collection. J Chron Dis 1987; 40: 41-49
14. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999; 149: 916-924
15. Robinson JR, Young TK, Roos LL, et al. Estimating the burden of disease: comparing administrative data and self-reports. Med Care 1997; 35: 932-947
16. Lix LM, Yogendran MS, Leslie WD, et al. Using multiple data features improved the validity of osteoporosis case ascertainment from administrative data. J Clin Epidemiol 2008; 61: 1250-1260
17. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512-516
18. Noyes K, Liu H, Holloway R, et al. Accuracy of medicare claims data in identifying Parkinsonism cases: comparison with the medicare current beneficiary survey. Mov Disord 2007; 22: 509-514
19. Roos NP, Mustard CM. Variation in health and health care use by socioeconomic status in Winnipeg, Canada: Does the system work well? Yes and no. Milbank Q 1997; 75: 89-111.
20. Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. Hoboken, NJ: Wiley, 2004.
21. McCulloch CE, Searle SR. Generalized, linear, and mixed models. New York: Wiley, 2001.
22. Lix L, Ekuma O, Brownell M, et al. A framework for modelling differences in regional mortality over time. J Epidemiol Community Health 2004; 58: 420-425
23. SAS Institute, Inc. SAS/STAT user's guide, version 9.1. Cary, NC: Author, 2004.
24. Svenson LW, Platt GH, Woodhead SE. Geographic variations in the prevalence rates of Parkinson's disease in Alberta. Can J Neurol Sci 1993; 20: 307-311
25. Svenson LW. Regional disparities in the annual prevalence rates of Parkinson's disease in Canada. Neuroepidemiology 1991; 10: 205-210
26. Noyes K, Liu H, Holloway R, et al. Economic burden associated with Parkinson's disease on elderly medicare beneficiaries. Mov Disord 2006; 21: 362-372
27. Clerke CE. Mortality from Parkinson's disease in England and Wales 1921-1989. J Neurol Neurosurg Psychiatry 1993; 56: 690-693
28. Goldman SM, Tanner CM, Olanow CW, et al. Occupation and parkinsonism in three movement disorders clinics. Neurology 2005; 65: 1430-1435
29. Tsiu JKC, Calne DB, Wang Y, et al. Occupational risk factors for Parkinson's disease. Can J Pub Health 1999; 90: 334-337
30. Alves G, Forsaa EB, Pedersen KF, et al. Epidemiology of Parkinson's disease. J Neurol 2008; 25S: 18-32.
31. Sterling T, Weinkam J. The confounding of occupation and smoking and its consequences. Soc Sci Med 1990; 30: 457-467
32. Elbez A, Tranchant C. Epidemiologic studies of environmental exposures in Parkinson's disease. J Neurol Sci 2007; 262: 37-44.
33. Swarztrauber K, Anau J, Peters D. Identifying and distinguishing cases of parkinsonism and Parkinson's disease using ICD-9 CM codes and pharmacy data. Mov Disord 2005; 20: 964-970
34. Rewson NSB, D'Arcy C. Assessing the validity of diagnostic information in administrative health care utilization data: experience in Saskatchewan. Pharmacoepidemiol Drug Saf 1998; 7: 389-398
35. Lai BC, Schulzer M, Marion S, et al. The prevalence of Parkinson's disease in British Columbia, Canada estimated by using drug tracer methodology. Parkinsonism Relet Disord 2003; 9: 233-238
36. Menniti-lppolito F, Spila-Alegiani S, Vanacore N, et al. Estimate of parkinsonism prevalence through drug prescription histories in the province of Rome, Italy. Acta Neurol Scand 1995; 92: 49-54.
37. Yiannakoullas N, Schopflocher DP, Warren A, et al. Parkinson's disease, multiple sclerosis and changes of residence in Alberta. Can J Neurol Sci 2007; 34: 343-348
38. Musterd CA, Derksen S, Bertholet JM, et al. Assessing ecological proxies for household income: A comparison of household and neighbourhood level income measures in the study of population health status. Health Place 1999; 5: 157-171
39. McMenamin H. Health problems more common in areas of heavy pesticide use. Interview with Jennifer Magoon. Pestie Toxic Chem News 2007; 35: 19-20.
40. Eskandar EN, Flaherty A, Cosgrove GR, et al. Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. J Neurosurg 2003; 99: 863-871